Levy Richard S

CIK 00014549837 companiesWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001454983

Recent Transactions

50 trades

Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$528.60/sh−440→ 21,237 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$518.53/sh−835→ 27,152 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$514.67/sh−146→ 29,551 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$522.70/sh−1,434→ 22,961 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$527.85/sh−200→ 21,677 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$517.51/sh−645→ 27,987 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$515.64/sh−919→ 28,632 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$520.68/sh−308→ 25,489 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$16.46/sh+6,000→ 29,697 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-11-13−6,000→ 4,000 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$523.66/sh−811→ 22,150 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$526.68/sh−120→ 21,877 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$7.36/sh+2,500→ 23,697 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$530.21/sh−40→ 21,197 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$519.67/sh−1,355→ 25,797 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-11-13−2,500→ 2,500 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$524.49/sh−153→ 21,997 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-13$521.79/sh−1,094→ 24,395 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-07-01+1,101→ 18,474 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-07-01−1,101→ 0 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-07-01+1,101→ 1,101 total
Award
Kodiak Sciences Inc.$KOD
Stock Option (Right to Buy)
2025-06-30+40,000→ 40,000 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-06-20+1,290→ 1,290 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-06-20+715→ 21,197 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2025-06-12+24,000→ 24,000 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-05−3,173→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-05+3,173→ 17,373 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-03+2,799→ 2,799 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-03+16,798→ 16,798 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2025-05-14$3.19/sh+20,000→ 51,000 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2025-05-14$3.19/sh+20,000→ 51,000 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-04-10$65.06/sh+9,470→ 20,482 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-04-10−9,470→ 0 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-11-07+1,303→ 1,303 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-11-07−1,303→ 0 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-11-07−5,000→ 5,000 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-11-07$350.00/sh−5,000→ 11,012 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-11-07$7.36/sh+5,000→ 16,012 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2024-11-07+1,303→ 14,200 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-11-01$300.10/sh−2,800→ 13,212 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-11-01$301.22/sh−1,100→ 12,112 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-11-01$304.29/sh−300→ 11,012 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-11-01$7.36/sh+5,000→ 16,012 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-11-01$302.25/sh−800→ 11,312 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-11-01−5,000→ 10,000 total
Award
Kodiak Sciences Inc.$KOD
Stock Option (Right to Buy)
2024-06-28+40,000→ 40,000 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-06-25+1,105→ 1,105 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-06-25+714→ 11,012 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2024-06-07+10,000→ 10,000 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2024-06-06+4,373→ 12,897 total

Companies

Recent Filings

Address

EXPERIMENTAL STATION ROUTE 141 AND HENRY CLAY RD

WILMINGTON, DE, 19880

View on SEC.gov